DBV Technologies | Revenu Net



Net Income Changement Date
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amarin USD -25134000 26.66M 2024-09
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
DBV Technologies USD -30442000 2.67M 2024-09
Halozyme Therapeutics USD 137.01M 1000 2024-12
Incyte USD 158.2M 43.01M 2025-03
Insmed USD -235548000 15.02M 2024-12
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
United Therapeutics USD 322.2M 20.9M 2025-03



DBV Technologies Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.